Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 25.65% is 230% above its 5-year average of 7.77%, near the high end of its 5-year range (-384.76%–81.62%).
120.59% above its 12-month average of -124.60%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 34.29%.
EBITDA MARGIN
25.65%
EBITDA MARGIN AVG TTM
-124.60%
EBITDA MARGIN AVG 3Y
-12.62%
EBITDA MARGIN AVG 5Y
7.77%
EBITDA MARGIN AVG 10Y
-25.33%
EBITDA MARGIN AVG 15Y
-159.87%
EBITDA MARGIN AVG 20Y
-130.65%
CURRENT VS TTM AVG
+120.59%
CURRENT VS 3Y AVG
+303.26%
CURRENT VS 5Y AVG
+230.13%
CURRENT VS 10Y AVG
+201.28%
CURRENT VS 15Y AVG
+116.04%
CURRENT VS 20Y AVG
+119.63%
SIGA Technologies, Inc.
Market Cap
$234.90M
EBITDA Margin
25.65%
TTM Avg
-124.60%
3Y Avg
-12.62%
5Y Avg
7.77%
Market Cap
$235.32M
EBITDA Margin
-1441.45%
TTM Avg
-4661.83%
3Y Avg
-5918.79%
5Y Avg
-3944.51%
Market Cap
$235.67M
EBITDA Margin
-163095.33%
TTM Avg
-97357.05%
3Y Avg
-88166.59%
5Y Avg
-88166.59%
Market Cap
$236.03M
EBITDA Margin
37.26%
TTM Avg
38.63%
3Y Avg
43.69%
5Y Avg
46.28%
Market Cap
$236.06M
EBITDA Margin
-1029.09%
TTM Avg
-1029.09%
3Y Avg
-1029.09%
5Y Avg
-1029.09%
Market Cap
$233.51M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$237.35M
EBITDA Margin
10.49%
TTM Avg
1.20%
3Y Avg
-4.19%
5Y Avg
-40.04%
Market Cap
$231.69M
EBITDA Margin
-43.93%
TTM Avg
-56.69%
3Y Avg
-115.93%
5Y Avg
-139.79%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SIGA Technologies, Inc. (SIGA) | $234.90M | 25.65% | -124.60% | -12.62% | 7.77% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $235.32M | -1441.45% | -4661.83% | -5918.79% | -3944.51% |
| InflaRx N.V. (IFRX)vs › | $235.67M | -163095.33% | -97357.05% | -88166.59% | -88166.59% |
| Utah Medical Products, Inc. (UTMD)vs › | $236.03M | 37.26% | 38.63% | 43.69% | 46.28% |
| BioAge Labs Inc. (BIOA)vs › | $236.06M | -1029.09% | -1029.09% | -1029.09% | -1029.09% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $233.51M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.35M | 10.49% | 1.20% | -4.19% | -40.04% |
| High Tide Inc. (HITI)vs › | $237.69M | 1.66% | 3.74% | -1.53% | 0.81% |
| MacroGenics, Inc. (MGNX)vs › | $231.69M | -43.93% | -56.69% | -115.93% | -139.79% |
| Invivyd, Inc. (IVVD)vs › | $239.07M | -100.05% | -392.29% | -392.29% | -392.29% |
Gross Margin
68.6%
EBITDA Margin
25.6%
Operating Margin
25.1%
Net Margin
-5.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 34.29% |
| 2026-03-31 | -82.84% |
| 2025-12-31 | -246.14% |
| 2025-09-30 | -384.76% |
| 2025-06-30 | 56.48% |
| 2025-03-31 | -30.11% |
| 2024-12-31 | 70.23% |
| 2024-09-30 | 6.70% |
| 2024-06-30 | 5.60% |
| 2024-03-31 | 44.88% |
| 2023-12-31 | 78.82% |
| 2023-09-30 | -12.70% |
| 2023-06-30 | -76.63% |
| 2023-03-31 | -23.76% |
| 2022-12-31 | -14.73% |
| 2022-09-30 | 59.55% |
| 2022-06-30 | 19.20% |
| 2022-03-31 | -12.44% |
| 2021-12-31 | 81.62% |
| 2021-09-30 | -58.09% |
| 2021-06-30 | 1.56% |
| 2021-03-31 | -38.61% |
| 2020-12-31 | 71.39% |
| 2020-09-30 | 74.62% |
| 2020-06-30 | 71.70% |
| 2020-03-31 | -147.53% |
| 2019-12-31 | -78.28% |
| 2019-09-30 | 9.75% |
| 2019-06-30 | -40.37% |
| 2019-03-31 | 22.27% |
| 2018-12-31 | -351.76% |
| 2018-09-30 | 78.31% |
| 2018-06-30 | -139.24% |
| 2018-03-31 | -257.74% |
| 2017-12-31 | -342.95% |
| 2017-09-30 | -404.34% |
| 2017-06-30 | -94.24% |
| 2017-03-31 | -81.38% |
| 2016-12-31 | -91.71% |
| 2016-09-30 | -172.15% |
| 2016-06-30 | -486.05% |
| 2016-03-31 | -552.48% |
| 2015-12-31 | -427.42% |
| 2015-09-30 | -269.41% |
| 2015-06-30 | -290.61% |
| 2015-03-31 | -416.15% |
| 2014-12-31 | -2078.87% |
| 2014-09-30 | -16521.39% |
| 2014-06-30 | -715.76% |
| 2014-03-31 | -1009.68% |
| 2013-12-31 | -681.86% |
| 2013-09-30 | -237.64% |
| 2013-06-30 | -573.06% |
| 2013-03-31 | -429.74% |
| 2012-12-31 | -204.72% |
| 2012-09-30 | -231.33% |
| 2012-06-30 | -230.52% |
| 2012-03-31 | -371.52% |
| 2011-12-31 | -154.55% |
| 2011-09-30 | -165.60% |
| 2011-06-30 | -438.60% |
| 2011-03-31 | -371.08% |
| 2010-12-31 | -133.41% |
| 2010-09-30 | -33.92% |
| 2010-06-30 | -64.10% |
| 2010-03-31 | -57.39% |
| 2009-12-31 | -91.23% |
| 2009-09-30 | -63.68% |
| 2009-06-30 | -59.60% |
| 2009-03-31 | -146.83% |
| 2008-12-31 | -97.67% |
| 2008-09-30 | -108.42% |
| 2008-03-31 | -84.11% |
| 2007-12-31 | -98.94% |
| 2007-09-30 | -78.16% |
| 2007-06-30 | -116.08% |
| 2007-03-31 | -81.30% |
| 2006-12-31 | -70.70% |
| 2006-09-30 | -25.21% |
| 2006-06-30 | -141.63% |
| 2006-03-31 | -71.77% |
| 2005-12-31 | -9.43% |
| 2005-09-30 | 35.35% |
| 2005-06-30 | -68.32% |
| 2005-03-31 | -51.32% |
| 2004-12-31 | -332.05% |
| 2004-09-30 | -296.33% |
| 2004-06-30 | -765.01% |
| 2004-03-31 | -1066.97% |
| 2003-12-31 | -1280.66% |
| 2003-09-30 | -751.81% |
| 2003-06-30 | -434.41% |
| 2003-03-31 | -392.33% |
| 2002-12-31 | -836.22% |
| 2002-09-30 | -617.48% |
